Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Goodin DS et al. – Results from these early treatment studies are presented, and the impact of using interferon beta treatment in the early stages of disease is discussed with the aim of considering optimal therapeutic strategies to improve long–term patient outcome.

Related Articles

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09    Relevance Score: 69%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09    Relevance Score: 69%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09    Relevance Score: 69%

Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
International Immunology, 10/14/09    Relevance Score: 68%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09    Relevance Score: 68%

Today in Demyelinating Disorders...keeping you current

The Progression of Regional Atrophy in Premanifest and Early Huntington’s Disease: A Longitudinal Voxel-Based Morphometry Study
Journal of Neurology, Neurosurgery, and Psychiatry , 12/17/09

Magnetic Resonance Evidence of Cerebellar Cortical Pathology in Multiple Sclerosis
Journal of Neurology, Neurosurgery, and Psychiatry , 12/17/09

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia
Journal of Neuroimmunology, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address